GBIO vs PMVP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 23, 2026

GBIO

42.9
AI Score
VS
GBIO Wins

PMVP

38.7
AI Score

Investment Advisor Scores

GBIO

43score
Recommendation
HOLD

PMVP

39score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric GBIO PMVP Winner
Forward P/E 7.874 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -78.9% 0.0% PMVP
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 42.9/100 38.7/100 GBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

GBIO 1M: -2.4% · 3M: +1.7% PMVP 1M: +9.7% · 3M: +5.4%

Current Technical Phase

GBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.7 · Price: $5.34

PMVP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.9% over 20 days), RSI 50

RSI (14): 50.5 · Price: $1.36

Fundamentals Snapshot

Metric GBIO PMVP
Market Cap — —
Forward P/E -0.7 -1.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.8% 0.0%
Gross Margin -2.1% —
Operating Margin -20.2% 0.0%
EPS -9.37 -1.42
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.